NeuroPace (NPCE) Revenue & Revenue Breakdown
NeuroPace Revenue Highlights
Latest Revenue (Y)
$79.91M
Latest Revenue (Q)
$27.35M
Main Geography (Y)
Non-US
NeuroPace Revenue by Period
NeuroPace Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $79.91M | 22.14% |
| 2023-12-31 | $65.42M | 43.72% |
| 2022-12-31 | $45.52M | 0.75% |
| 2021-12-31 | $45.18M | 9.83% |
| 2020-12-31 | $41.14M | 11.27% |
| 2019-12-31 | $36.97M | - |
NeuroPace generated $79.91M in revenue during NA 2024, up 22.14% compared to the previous quarter, and up 216.13% compared to the same period a year ago.
NeuroPace Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $27.35M | 16.30% |
| 2025-06-30 | $23.52M | 4.42% |
| 2025-03-31 | $22.52M | 4.93% |
| 2024-12-31 | $21.47M | 1.93% |
| 2024-09-30 | $21.06M | 9.37% |
| 2024-06-30 | $19.26M | 6.25% |
| 2024-03-31 | $18.12M | 0.62% |
| 2023-12-31 | $18.01M | 9.65% |
| 2023-09-30 | $16.43M | -0.50% |
| 2023-06-30 | $16.51M | 14.08% |
| 2023-03-31 | $14.47M | 13.16% |
| 2022-12-31 | $12.79M | 14.63% |
| 2022-09-30 | $11.16M | 9.38% |
| 2022-06-30 | $10.20M | -10.32% |
| 2022-03-31 | $11.37M | 3.43% |
| 2021-12-31 | $11.00M | 6.36% |
| 2021-09-30 | $10.34M | -18.14% |
| 2021-06-30 | $12.63M | 12.60% |
| 2021-03-31 | $11.22M | 4.32% |
| 2020-12-31 | $10.75M | -15.81% |
| 2020-09-30 | $12.77M | 67.16% |
| 2020-06-30 | $7.64M | -23.41% |
| 2020-03-31 | $9.97M | - |
NeuroPace generated $27.35M in revenue during Q3 2025, up 16.30% compared to the previous quarter, and up 142.05% compared to the same period a year ago.
NeuroPace Revenue Breakdown
NeuroPace Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 |
|---|---|---|
| Non-US | $200.00K | $100.00K |
Latest
NeuroPace's latest annual revenue breakdown by geography, as of Dec 24: Non-US (100.00%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 |
|---|---|---|
| Non-US | $400.00K | $100.00K |
Latest
NeuroPace's latest quarterly revenue breakdown by geography, as of Jun 25: Non-US (100.00%).
NeuroPace Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CERS | Cerus | $180.27M | $52.70M |
| RXST | RxSight | $139.93M | $33.64M |
| NPCE | NeuroPace | $79.91M | $27.35M |
| SGHT | Sight Sciences | $79.87M | $19.91M |
| MASS | 908 Devices | $59.63M | $14.01M |
| CVRX | CVRx | $51.29M | $14.69M |
| BWAY | BrainsWay | $31.79M | $9.10M |
| DCTH | Delcath Systems | $31.02M | - |
| SENS | Senseonics | $22.47M | $8.10M |
| GNLX | Genelux | $8.00K | - |
| ALDX | Aldeyra Therapeutics | - | - |